Graco vs Xylem
GGG and XYL side by side, both in general industrial machinery and equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GGG and XYL compare
Xylem is the larger company, worth 1.9 times as much as Graco ($21.7B against $11.4B).
On earnings, Xylem is cheaper: it trades at 20.9× trailing earnings, against 22.8× for Graco.
Graco grew revenue faster over the last twelve months (5.4% versus 1.9% for Xylem).
Graco keeps more of each dollar of sales as profit, with a net margin of 22.4% compared with 11.9% at Xylem.
Both pay dividends: Graco yields 1.7% and Xylem 1.8%.
Xylem scores higher on the StockData Score (24 against 18 for Graco), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GGG | XYL |
|---|---|---|
| Size and price | ||
| Market cap | $11.4B | $21.7B |
| Share price | $71.04 | $94.65 |
| Change, 1 year | −11.4% | −33.7% |
| Change, 5 years | −5.4% | −22.8% |
| Beta (5Y) | 0.43 | 0.18 |
| Employees | 4,400 | 22K |
| StockData Score | ||
| Total score | 18 | 24 (better) |
| Valuation score | 4 | 6 (better) |
| Growth score | 0 | 4 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 5 | 6 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 22.8× | 20.9× (better) |
| P/S | 4.9× | 2.4× (better) |
| P/B | 4.6× | 2.1× (better) |
| EV/EBITDA | 15.6× (better) | 17.4× |
| P/FCF | 19.0× (better) | 23.6× |
| PEG | 4.56 | 0.81 (better) |
| FCF yield | 5.3% (better) | 4.2% |
| Fair value | $77.53 | $119.17 |
| Margin of safety | 8.4% | 20.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.4% (better) | 1.9% |
| Revenue growth, 5Y average | 6.3% | 13.1% (better) |
| Net income growth (TTM) | 3.9% | 14.1% (better) |
| EPS growth (TTM) | 6.1% | 16.2% (better) |
| EPS growth, 5Y average | 9.9% | 22.9% (better) |
| Profitability | ||
| Gross margin | 52.0% (better) | 39.8% |
| Operating margin | 26.8% (better) | 15.1% |
| Net margin | 22.4% (better) | 11.9% |
| FCF margin | 26.0% (better) | 10.2% |
| Return on equity | 20.4% (better) | 10.1% |
| Return on invested capital | 22.8% (better) | 9.0% |
| Financial health | ||
| Debt / equity | 0.04 (better) | 0.28 |
| Net debt / EBITDA | −0.05 | 1.59 (better) |
| Interest coverage | 189× (better) | 36.1× |
| Current ratio | 2.12 (better) | 1.39 |
| Altman Z-score | 10.72 (better) | 3.11 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | 1.8% (better) |
| Payout ratio | 36.9% | 37.4% |
| Years of dividend growth | 16 (better) | 13 |
| Dividend growth, 5Y average | 9.5% (better) | 9.0% |
| Buyback yield | 4.1% | 7.3% (better) |
| Shareholder yield | 5.7% | 9.1% (better) |
| Ownership | ||
| Held by institutions | 93.1% | 94.9% |
| Held by insiders | 1.0% | 0.20% |
| Insider net buying, 12 months | −$3.9M | $625K (better) |
| Short interest, % of float | 3.7% | 3.8% |
Go deeper
- GGG stock overview
- GGG income statement
- GGG valuation and score
- XYL stock overview
- XYL income statement
- XYL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.